Cumulative time on HAART increases health risks to both mother and foetus
Risk of severe liver toxicities if nevirapine used in HAART in pregnant women with CD4 above 250
Breastfeeding and HIV transmission
HIV-positive women less likely to become pregnant and more likely to miscarry even if asymptomatic
Rapid HIV tests should be used on women in labour
MTCT-plus: Family-focused care and treatment
Preventing mother-to-child transmission of HIV
Timing of nevirapine for newborns: extra syrup for baby if mother late to dose
